Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Apathy in Parkinson's Disease
NCT00755027Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Sep 2008
- Primary completion
- Jun 2014
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in apathy comparing Rasagiline with Placebo (2 arms). Primary endpoints: Lille Apathy Rating Scale at 12 weeks and Apathy Scale at 12 weeks. Started Sep 2008; status: completed.
02
Drugs
rasagiline
03
Conditions
apathy
Beyond the preview
Go deeper on NCT00755027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755027.